TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.

about

Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others.

P2860

Q47742599-E2FBD5FF-2920-494F-B90E-AF4A85B5B257

P2860

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.

Item

http://www.wikidata.org/entity/Q36376097

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.

@ast

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.

@en

type

Item

label

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.

@ast

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.

@en

prefLabel

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.

@ast

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.

@en

P1476

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.

@en

P2093

Chin-Hao Chang

http://www.w3.org/2001/XMLSchema#string

Chung-Chieh Wang

http://www.w3.org/2001/XMLSchema#string

Dwan-Ying Chang

http://www.w3.org/2001/XMLSchema#string

Fu-Chang Hu

http://www.w3.org/2001/XMLSchema#string

I-Chiun Chen

http://www.w3.org/2001/XMLSchema#string

Ming-Yang Wang

http://www.w3.org/2001/XMLSchema#string

Pei-Fang Wu

http://www.w3.org/2001/XMLSchema#string

Wei-Wu Chen

http://www.w3.org/2001/XMLSchema#string

Wen-Hung Kuo

http://www.w3.org/2001/XMLSchema#string

Yen-Shen Lu

http://www.w3.org/2001/XMLSchema#string

P2860

COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

Comprehensive molecular portraits of human breast tumours

Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management: a systematic review and cost-effectiveness analysis

The rebel angel: mutant p53 as the driving oncogene in breast cancer.

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer.

A gene-expression signature as a predictor of survival in breast cancer

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database

Supervised risk predictor of breast cancer based on intrinsic subtypes

P2888

srep17879

P304

17879

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP17879

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2015-12-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

287203398

http://www.w3.org/2001/XMLSchema#string

P698

26671300

http://www.w3.org/2001/XMLSchema#string

P932

4680865

http://www.w3.org/2001/XMLSchema#string

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.

about

P2860

P2860

TP53 Mutational Analysis Enhances the Prognostic Accuracy of IHC4 and PAM50 Assays.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P478

P50

P577

P5875

P698

P932